Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing Forms of MS”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Large-scale testing (Phase 3)Study completedNCT01201356
What this trial is testing

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 4,125
Not applicableUnknownNCT00914758
What this trial is testing

Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Washington Neuropsychology Research Group 1
Testing effectiveness (Phase 2)Study completedNCT05798520
What this trial is testing

Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Biogen 127
Not applicableEnded earlyNCT04746976
What this trial is testing

Study of Diroximel Fumarate in the Real-World Setting

Who this might be right for
Relapsing Forms of MS
Biogen 75
Large-scale testing (Phase 3)Study completedNCT01199861
What this trial is testing

Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis 138
Testing effectiveness (Phase 2)Ended earlyNCT01950234
What this trial is testing

ACTH in Progressive Forms of MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
University of Minnesota 59
Not applicableStudy completedNCT06251986
What this trial is testing

A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 310
Post-approval studies (Phase 4)Study completedNCT03589105
What this trial is testing

Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting

Who this might be right for
Multiple Sclerosis
Hoffmann-La Roche 423
Not applicableStudy completedNCT01070836
What this trial is testing

JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab

Who this might be right for
Relapsing Multiple Sclerosis
Biogen 35,895
Early research (Phase 1)Ended earlyNCT01144351
What this trial is testing

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Elan Pharmaceuticals 32
Large-scale testing (Phase 3)Study completedNCT00472797
What this trial is testing

Rebif New Formulation (RNF) Quality of Life (QOL) Study

Who this might be right for
Relapsing Multiple Sclerosis
EMD Serono 232
Not applicableStudy completedNCT01080014
What this trial is testing

Correlation Between Multiple Sclerosis Functional Composite (MSFC) and Expanded Disability Status Scale (EDSS) in Patients With Multiple Sclerosis (MS) in Argentina

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 252
Post-approval studies (Phase 4)Study completedNCT00176592
What this trial is testing

Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI

Who this might be right for
Multiple Sclerosis
University of Medicine and Dentistry of New Jersey 75
Post-approval studies (Phase 4)Study completedNCT02307838
What this trial is testing

Long-term Follow-up of Fingolimod Phase II Study Patients

Who this might be right for
Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 177
Testing effectiveness (Phase 2)Study completedNCT00109161
What this trial is testing

Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
PDL BioPharma, Inc. 270
Testing effectiveness (Phase 2)Study completedNCT00436826
What this trial is testing

Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)

Who this might be right for
Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 172
Not applicableLooking for participantsNCT05658497
What this trial is testing

Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

Who this might be right for
Multiple Sclerosis
Biogen 908
Post-approval studies (Phase 4)Study completedNCT03784898
What this trial is testing

Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving Lemtrada

Who this might be right for
Multiple Sclerosis
Genzyme, a Sanofi Company 13
Not applicableLooking for participantsNCT05688436
What this trial is testing

Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies

Who this might be right for
Multiple Sclerosis
Biogen 1,178
Post-approval studies (Phase 4)Study completedNCT01591551
What this trial is testing

NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Cornerstone Health Care, PA 37
Load More Results